AstraZeneca CEO Soriot Speaks on $6.9 Billion Cancer Therapy Deal

AstraZeneca CEO Soriot on Pharmaceuticals in ChinaПодробнее

AstraZeneca CEO Pascal Soriot goes one-on-one with Jim CramerПодробнее

AstraZeneca CEO Pascal Soriot breaks down data on new 'transformative' breast cancer drugПодробнее

Soriot: the CEO who fought a bidПодробнее

Pascal Soriot, AstraZeneca: Real Innovation Requires RiskПодробнее

AstraZeneca CEO: Objective is to replace chemotherapyПодробнее

AstraZeneca CEO on Cancer Treatment, Covid in ChinaПодробнее

AstraZeneca CEO Pascal Soriot on progress on pancreatic cancerПодробнее

AstraZeneca 'within striking distance' of curing some cancers, CEO says | CNBC ConversationПодробнее

AstraZeneca CEO on Impact of Midterms on Drug MarketПодробнее

Pharma industry has a trust issue, AstraZeneca CEO says | CNBC ConversationПодробнее

Leaders with Lacqua: Astrazeneca CEO Pascal SoriotПодробнее

Bloomberg Turnaround: How a CEO Doubled His Company's Share PriceПодробнее

Patients are returning and we see a good third quarter ahead, says AstraZeneca CEOПодробнее

AstraZeneca CEO on Cancer, Obesity & Mars!Подробнее

CEO Pascal Soriot in conversation with Mene Pangalos, EVP, BioPharmaceuticals R&DПодробнее

CEO Pascal Soriot reflects on AstraZeneca's H1 2019 ResultsПодробнее

CEO Series: Pascal SoriotПодробнее